Antonio Waldo Zuardi Selected Research

Antonio Waldo Zuardi Research Topics

Disease

9	Schizophrenia (Dementia Praecox) 01/2020 - 06/2004
6	Social Phobia 10/2019 - 06/2007
3	Cognitive Dysfunction 05/2022 - 03/2010
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2022 - 01/2019
3	Psychotic Disorders (Schizoaffective Disorder) 01/2015 - 07/2005
2	Parkinson Disease (Parkinson's Disease) 06/2022 - 09/2008
2	Hyperalgesia 12/2021 - 01/2019
2	Nausea 01/2017 - 09/2008
2	Memory Disorders (Memory Loss) 12/2015 - 08/2015
2	Inflammation (Inflammations) 10/2015 - 01/2015
1	REM Sleep Behavior Disorder 06/2022
1	Restless Legs Syndrome (Restless Legs) 06/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Mental Disorders (Mental Disorder) 01/2020
1	Autism Spectrum Disorder 01/2020
1	Neurobehavioral Manifestations 01/2019
1	Tachycardia (Tachyarrhythmias) 01/2017
1	Dizziness (Lightheadedness) 01/2017
1	Ischemia 10/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Meningitis 12/2012
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 12/2012
1	Paranoid Schizophrenia (Delusional Disorder) 08/2011
1	Marijuana Abuse (Cannabis Abuse) 05/2010
1	Alzheimer Disease (Alzheimer's Disease) 09/2008
1	Rheumatoid Arthritis 09/2008
1	Brain Ischemia (Cerebral Ischemia) 09/2008
1	Neoplasms (Cancer) 09/2008
1	Panic Disorder (Panic Attack) 10/2006
1	Treatment-Resistant Schizophrenia 09/2006
1	Catatonic Schizophrenia 07/2005
1	Catatonia 07/2005
1	Lipoma (Lipomata) 02/2002

Drug/Important Bio-Agent (IBA)

18	CannabidiolIBA 06/2022 - 09/2006
5	Anti-Anxiety Agents (Anxiolytics)IBA 05/2022 - 05/2010
5	CannabinoidsIBA 01/2020 - 03/2010
4	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 01/2012
3	EndocannabinoidsIBA 10/2019 - 08/2011
2	Pharmaceutical PreparationsIBA 05/2022 - 01/2015
2	Dronabinol (THC)FDA LinkGeneric 01/2017 - 05/2010
2	Caffeine (No Doz)FDA LinkGeneric 12/2015 - 08/2015
2	CytokinesIBA 01/2015 - 12/2012
2	anandamide (arachidonylethanolamide)IBA 01/2015 - 08/2011
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 06/2007 - 10/2006
2	Clozapine (Clozaril)FDA LinkGeneric 07/2005 - 02/2002
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 12/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021
1	cannabidivarinIBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	nabilone (Cesamet)FDA Link 01/2017
1	Interleukin-1 (Interleukin 1)IBA 10/2015
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2015
1	OvalbuminIBA 01/2015
1	AllergensIBA 01/2015
1	Nitric Oxide DonorsIBA 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015
1	NeuropeptidesIBA 12/2014
1	Oxytocin (Pitocin)FDA LinkGeneric 12/2014
1	ChemokinesIBA 12/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2012
1	Indicators and Reagents (Reagents)IBA 02/2012
1	RimonabantIBA 01/2012
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 08/2011
1	Messenger RNA (mRNA)IBA 08/2011
1	agomelatine (S20098)IBA 10/2010
1	Therapeutic UsesIBA 09/2008
1	Protons (Proton)IBA 06/2004

Therapy/Procedure

1	Therapeutics 01/2020
1	Aftercare (After-Treatment) 01/2017
1	Intraperitoneal Injections 12/2012